This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1093/annonc/mdz453.001
Other

LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042

..., Tony Mok
118
Annals of Oncology56.70
Volume: 30, Pages: xi63 - xi64
Published: Dec 1, 2019
Abstract
No abstract.
Paper Fields
Paper Details
Title
LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042
DOI
doi.org/10.1093/annonc/mdz453.001
Published Date
Dec 1, 2019
Journal
Annals of Oncology
Volume
30
Pages
xi63 - xi64
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.